osimertinib
astrazeneca
['nsclc', 'osimertinib', 'sclc']
the #oncoalerttoptweet day1 of #asco23 tweet by our oncoalert faculty dr. presents results from phase ii study of neoadjuvant osimertinib for resectable #egfr nsclc (thread) best 
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨